Palmitoylethanolamide

a cannabinoid receptor-inactive eCB-related molecule used as prophylactic in helping to prevent respiratory viral infection

300 PubMed studies analyzed · 28 RCTs · Evidence Score: 49.1

Research Domains

Palmitoylethanolamide has been studied across 24 research domains including 💊 Pain, 🔬 Inflammation, 🧠 Neuroprotection, 🔥 Metabolic, 🔬 Oncology. The primary research focus is 💊 Pain with 29% of studies addressing this area.

Loading evidence profile...

This evidence profile for Palmitoylethanolamide is generated deterministically from 300 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.